Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
45
CTVA Quote, Financials, Valuation and Earnings
Last price:
$74.50
Seasonality move
:
0.42%
Day range:
$74.33 - $75.91
52-week range:
$53.40 - $77.41
Dividend yield:
0.93%
P/E ratio:
47.56x
P/S ratio:
2.95x
P/B ratio:
2.10x
Volume:
5.7M
Avg. volume:
4M
1-year change:
19.61%
Market cap:
$50.6B
Revenue:
$17.4B
EPS (TTM):
$1.58
Analysts' Opinion
-
Consensus RatingCorteva, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 12 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $81.57, Corteva, Inc. has an estimated upside of 8.3% from its current price of $75.32.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $65.00 representing 13.7% downside risk from its current price of $75.32.
Fair Value
-
According to the consensus of 19 analysts, Corteva, Inc. has 8.3% upside to fair value with a price target of $81.57 per share.
CTVA vs. S&P 500
-
Over the past 5 trading days, Corteva, Inc. has overperformed the S&P 500 by 0.13% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Corteva, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Corteva, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Corteva, Inc. reported revenues of $3.9B.
Earnings Growth
-
Corteva, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Corteva, Inc. reported earnings per share of -$0.82.
Enterprise value:
48.9B
EV / Invested capital:
1.81x
Price / LTM sales:
2.95x
EV / EBIT:
20.07x
EV / Revenue:
2.81x
PEG ratio (5yr expected):
2.06x
EV / Free cash flow:
17.38x
Price / Operating cash flow:
18.22x
Enterprise value / EBITDA:
13.44x
Gross Profit (TTM):
$7.4B
Return On Assets:
2.87%
Net Income Margin (TTM):
6.92%
Return On Equity:
4.83%
Return On Invested Capital:
4.23%
Operating Margin:
5.73%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $17.2B | $16.9B | $17.4B | $4B | $3.9B | |
| Gross Profit | $6.7B | $6.8B | $7.4B | $1.4B | $1.5B | |
| Operating Income | $2.2B | $2.2B | $2.4B | $280M | $224M | |
| EBITDA | $3.4B | $3.4B | $3.6B | $582M | $530M | |
| Diluted EPS | $1.02 | $1.29 | $1.58 | -$0.06 | -$0.82 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $15.5B | $16.8B | $16.3B | $15.1B | $17.3B | |
| Total Assets | $42.3B | $42.6B | $43B | $40.8B | $42.8B | |
| Current Liabilities | $9.6B | $10.7B | $10.4B | $10.4B | $12.1B | |
| Total Liabilities | $16.7B | $17.1B | $17.7B | $16.8B | $18.5B | |
| Total Equity | $25.6B | $25.5B | $25.3B | $24B | $24.4B | |
| Total Debt | $1.4B | $1.6B | $2.8B | $2.8B | $2.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.8B | $2.1B | $3.4B | $4.2B | $4.4B | |
| Cash From Investing | -$2B | -$589M | -$543M | -$123M | -$188M | |
| Cash From Financing | -$99M | -$1.2B | -$1.6B | -$3.3B | -$2.2B | |
| Free Cash Flow | $1.2B | $1.5B | $2.8B | $4B | $4.2B | |
CTVA
Sector
Market Cap
$50.6B
$24.1M
Price % of 52-Week High
97.3%
74.62%
Dividend Yield
0.93%
0%
Shareholder Yield
4.62%
-2.99%
1-Year Price Total Return
19.61%
22.5%
Beta (5-Year)
0.750
0.595
Dividend yield:
0.93%
Annualized payout:
$0.70
Payout ratio:
8.84%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$73.95
200-day SMA
Buy
Level
$69.16
Bollinger Bands (100)
Buy
Level
63.25 - 70.51
Chaikin Money Flow
Buy
Level
5.5M
20-day SMA
Buy
Level
$72.53
Relative Strength Index (RSI14)
Buy
Level
66.39
ADX Line
Buy
Level
19.04
Williams %R
Neutral
Level
-24.9057
50-day SMA
Buy
Level
$69.21
MACD (12, 26)
Buy
Level
20.39
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Neutral
Level
27.7M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.2161)
Buy
CA Score
(Annual)
Level (0.3146)
Buy
Beneish M-Score
(Annual)
Level (-2.4841)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-1.9166)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Corteva, Inc. engages in the provision of seed and crop protection solutions. It focuses on the agriculture industry and food supply. It operates through the Seed and Crop Protection segments. The Seed segment is involved in the development and supply of advanced germplasm and traits that produce yield for farms. The Crop Protection segment includes the global agricultural input industry with products for weeds, insects, other pests, and diseases protection, through nitrogen management and seed-applied technologies. The company was founded in 1802 and is headquartered in Indianapolis, IN.
Stock Forecast FAQ
In the current month, CTVA has received 12 Buy ratings 7 Hold ratings, and 0 Sell ratings. The CTVA average analyst price target in the past 3 months is $81.57.
-
Where Will Corteva, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Corteva, Inc. share price will rise to $81.57 per share over the next 12 months.
-
What Do Analysts Say About Corteva, Inc.?
Analysts are divided on their view about Corteva, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Corteva, Inc. is a Sell and believe this share price will drop from its current level to $65.00.
-
What Is Corteva, Inc.'s Price Target?
The price target for Corteva, Inc. over the next 1-year time period is forecast to be $81.57 according to 19 Wall Street analysts, 12 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is CTVA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Corteva, Inc. is a Buy. 12 of 19 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CTVA?
You can purchase shares of Corteva, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Corteva, Inc. shares.
-
What Is The Corteva, Inc. Share Price Today?
Corteva, Inc. was last trading at $74.50 per share. This represents the most recent stock quote for Corteva, Inc.. Yesterday, Corteva, Inc. closed at $75.32 per share.
-
How To Buy Corteva, Inc. Stock Online?
In order to purchase Corteva, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CTVA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CTVA
Sector
P/E ratio
47.56x
20.19x
PEG ratio
2.06x
-0.02x
P/B ratio
2.10x
1.91x
Price / LTM sales
2.95x
1.73x
Growth Metrics
CTVA
Sector
Revenue growth
-1.71%
2.37%
Earnings growth
-1272.65%
--
Revenue (5-year growth)
4.13%
3.24%
Earnings forecast
$0.22
$0.03
Profitability
CTVA
Sector
Profitability FY 2025
$7.6B
--
Return on invested capital
4.23%
-9.18%
Return on assets
2.87%
-10.59%
Return on equity
4.83%
-9.79%
Earnings Date
Last Earnings Date
Feb
3
Next Earnings Date
May
6
Estimated Next Earnings Date
May
5
Balance Sheet
CTVA
Sector
Total cash
$4.5B
$2.6M
Short term investments
$63M
$217K
Total assets
$42.8B
$16.7M
Long term debt
$2.6B
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 10.82% over the past day.
Buy
67
DIOD alert for Feb 12
Diodes, Inc. [DIOD] is down 7.42% over the past day.
Buy
77
VRT alert for Feb 12
Vertiv Holdings Co. [VRT] is down 4.75% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
